On Thursday 19 June at 14:00, Maj Bangshaab defends her PhD dissertation entitled "Metabolic aspects of 3-hydroxybutyrate in diabetes - In health and disease".

3-hydroxybutyrate, commonly referred to as “ketones,” is a natural energy source in the human body and previously primarily known for leading to the serious complication diabetic ketoacidosis in individuals with type 1 diabetes. However, recent research has shown a range of health benefits associated with ketone supplementation. A new PhD project from Aarhus University, Health, has investigated the effects of ketones in individuals with type 1 and type 2 diabetes. The project was carried out by Maj Bangshaab, who is defending her dissertation on June 19, 2025.

Results from the PhD project showed that intake of ketone supplements lowers blood sugar and blood fatty acid levels in individuals with type 2 diabetes. These effects may potentially reduce the risk of developing long-term complications such as cardiovascular disease, suggesting that ketone supplements could be a promising treatment option for type 2 diabetes.

Furthermore, the studies showed how ketones reduce the release of fatty acids in the body of individuals with type 1 diabetes. This, in turn, limits further ketone production in the body and may serve as a protective mechanism against ketone levels becoming critically high, which could otherwise lead to diabetic ketoacidosis.

The summary is written by the PhD student.

The defence is public and takes place in Auditorium Verdensrummet, Steno Diabetes Center Aarhus, Aarhus University Hospital. Please see the press release for more information. 

Contact

PhD student Maj Bangshaab
Mail: bangshaab@clin.au.dk 
Phone: 30334546

Read full press release